Additional file 1 of Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy

Additional file 1: Table S1. Gene list of Onco-LymScan panel. Table S2. Overview of patient characteristics. Table S3. Demographic of patient characteristics. Table S4. Sequencing quality data of tumor gDNA samples. Table S5. Sequencing quality data of cfDNA samples. Table S6. Univariate Cox proportional hazard regression survival analysis including pretreatment ctDNA levels and other clinical indices.

附加文件1：表S1。Onco-LymScan 基因检测面板（Onco-LymScan panel）的基因列表。表S2。患者特征概况。表S3。患者人口统计学特征。表S4。肿瘤基因组脱氧核糖核酸（genomic DNA, gDNA）样本测序质量数据。表S5。循环游离DNA（circulating cell-free DNA, cfDNA）样本测序质量数据。表S6。包含治疗前循环肿瘤DNA（circulating tumor DNA, ctDNA）水平及其他临床指标的单因素Cox比例风险回归生存分析结果。